EDINBURGH, Scotland, May 4, 2017 /PRNewswire/ --
By adding Apple Watch as another display device, Europeans living with diabetes have even more options to view their glucose readings and alerts on Dexcom's G5 Mobile CGM System to help better manage their diabetes
Dexcom, Inc. (NASDAQ: DXCM), the leader in Continuous Glucose Monitoring (CGM) for people with diabetes, announced today that its G5 Mobile CGM System can now be used with Apple Watches throughout Europe by downloading the latest version of the G5 Mobile App - iOS 1.6.
In addition to Apple Watch compatibility, the following additional features are now available in iOS 1.6:
Mute Override - With this feature, users can receive certain Dexcom system alerts, even when the phone sound is off, set to vibrate, or in 'Do Not Disturb' mode.
Vibrate-Only Sound Option - With this feature, users can choose to use vibrate-only as the sound for Low and High Glucose alerts, Rise and Fall Rate, and Signal Loss. Vibrate-only is not available for Urgent Low Glucose Alarm or other critical system alerts.
Apple Today View Widget - With this feature, users can check their CGM information on their compatible smart device without the need to open the G5 Mobile App, even when the device is locked.
"Dexcom is rapidly advancing technology for continuous glucose monitoring devices to improve diabetes management. These advances are making diabetes management more convenient and flexible than ever before," stated John Lister, General Manager EMEA, Dexcom. "We are excited for the promise our CGM technology holds for people with diabetes and caregivers as we further expand our offerings into the European market."
About Dexcom, Inc.
Founded in 1999, Dexcom, Inc. has corporate offices in San Diego, California, EMEA headquarters in Edinburgh, Scotland and users in 39 countries around the world. At Dexcom, we are transforming diabetes care and management by providing superior Continuous Glucose Monitoring (CGM) technology to help people with diabetes and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for people with diabetes, caregivers, and clinicians by delivering solutions that are best in class-while empowering our community to take control of diabetes. For more information on Dexcom CGM, visit http://www.Dexcom.com.
Enhanced Mobility and Flexibility
The Dexcom G5 Mobile CGM System is the world's first CE marked mobile CGM system that is compatible on both iOS and Android platforms. This CGM system provides consistent, accurate sensing performance with MARD of 9% for adults and 10% for children as young as two years old. (MARD or Mean Absolute Relative Difference is an important industry standard for measurement where the lower the MARD the more accurate the sensor). The G5 Mobile System also offers the longest-wear sensor on the market and provides users with the freedom to make treatment decisions without the need for confirmatory fingersticks. The G5 Mobile System features real-time customisable alerts and a built-in low glucose alarm (3.1 mmol/L; 55 mg/dL) to help users respond quickly to or avoid potentially dangerous hypoglycaemic events. Users can also customise alerts notifying them of impending lows and highs. In addition, the G5 Mobile CGM System offers users the ability to stay connected in real-time with loved ones by sharing their CGM data with up to five followers via the Follow App.
Diabetes: A World-Wide Emergency
Each year more and more people live with diabetes, which can result in life-changing complications. In addition to the 415 million adults who are estimated to currently have diabetes, there are 318 million adults with impaired glucose tolerance, which puts them at high risk of developing the disease in the future. According to the International Diabetes Foundation (IDF), there are 52 million people living with diabetes in Europe and by 2040, it is estimated that more than 72 million people will have the disease. With diabetes, the body cannot produce or use the hormone insulin effectively, causing a buildup of glucose, or sugar, in the blood. We believe there are also approximately 17 million people in Europe who have diabetes but have not been diagnosed. They may have symptoms they can't explain, or they may assume that the symptoms are due to other causes, such as getting older or having a busy lifestyle. People with diabetes who take insulin must monitor their blood glucose levels frequently. Uncontrolled glucose can cause health complications and even death.,
- Data from StatCounter, Statista, & Kantar World Panel (http://gs.statcounter.com/#mobile_os-ww-monthly-201505-201605 and http://www.kantarworldpanel.com/global/smartphone-os-market-share/).
- Laffel, L. Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus - Results from Two Studies DT&T Vol 18, Supplement 2, 2016. Bailey, Chang, Christiansen. Clinical Accuracy of a Continuous Glucose Monitoring System with an Advanced Algorithm. J Diabetes Sc Tech 2015 Vol 9(2) 209-214.
- If your glucose alerts and readings do not match your symptoms or expectations or you are taking medications containing paracetamol/acetaminophen, you should perform a fingerstick to confirm your blood glucose level. A fingerstick is needed every 12 hours to calibrate.
- IDF Diabetes Atlas 2015.
- Hyperglycemia (High blood glucose). American Diabetes Association Web site. http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/hyperglycemia.html. Updated September 16, 2014. Accessed November 7, 2016.
- Hypoglycemia (Low blood glucose). American Diabetes Association Web site. http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/hypoglycemia-low-blood.html. Updated July 1, 2015. Accessed November 7, 2016.
Sara Stephens, +44-203-551-7766
To view multimedia assets, please visit: https://www.dexcom.com/media
Steven Pacelli, +1-858-200-0200
SOURCE Dexcom, Inc.